Friday, November 6, 2020 | 6:00 PM ESTSupported by an educational grant from Gilead Sciences VISIT EVENT NOW Session Description: Join this lively discussion of the latest RA treatment trends, […]
Friday, November 6, 2020 | 6:00 PM EST Supported by Boehringer Ingelheim Pharmaceuticals, Inc. VISIT EVENT NOW Primary Session Topic: Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics) Session […]
Friday, November 6, 2020 | 2:00 PM ESTSupported by Boehringer Ingelheim Pharmaceuticals, Inc. VISIT EVENT NOW Primary Session Topic:Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics) Session Description: Join […]
The ACR’s six special COVID-19 sessions—including one with Anthony S. Fauci, MD, ACR Master and NIAID director—will share important insights into the current pandemic.
Even before the COVID-19 pandemic moved it to an all-virtual meeting, organizers had already transformed and reimagined ACR Convergence 2020 into something better than ever. “In the future, 2020 will be viewed as the year education in rheumatology was transformed. I hope you will make plans to join us at this unique time in history,”…
The updated guideline provides clinicians with evidence-based guidance on important topics such as the optimal usage of urate-lowering therapy (ULT), treatment of gout flares, managing lifestyle factors, and other medication recommendations to help them be successful in optimally managing gout in their patients.
“We need to think about for each individual what are the puzzle pieces that should go together to help manage their osteoarthritis,” said Tuhina Neogi, MD, PhD, FRCPC. “There’s no one size fits all for patients.”
Here’s just a sample of the great education that was available during the meeting that took place in Atlanta. Miss a session at this year’s Annual Meeting? 2019 Annual Meeting scientific registrants receive a complimentary 12-month subscription to ACR Beyond On-Demand.
The ACR thanks you for joining your colleagues from around the world and for helping make the meeting a great experience! See you next year in Washington, DC!
Premenopausal osteoporosis presents a particularly complex clinical challenge because it’s not particularly common and there’s no clear indication for treatment in premenopausal women.